ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

Blog - Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

Read the blog

Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. These concepts align the strategy with global clinical development and measure key factors necessary for meeting the unique needs of the Sponsor.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

The Altascientist Scientific journal
E-Bulletins Highlights on key topics
Newsletters Latest industry and corporate news
Scientific Publications Posters, case studies and abstracts
Blog
Videos

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

A starry night with chemical-like webbing and the words "Altasciences Acquires WCCT Global" written over top.

Press Release

Altasciences Acquires WCCT Global

Altasciences is expanding its current clinical operations in Montreal and Kansas City with the addition of a clinical CRO on the U.S.A.'s West Coast. Click below to read more about the acquisition of WCCT Global.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Altasciences Events
Press Releases
Altasciences in the News
Press Kit
Webinars / Podcasts

Our Solutions

September 2018

DID YOU KNOW? Algorithme Pharma, Algorithme Pharma USA and Vince & Associates Clinical Research have been part of Altasciences for over 5 years now!
Altasciences Clinical Research - Newsletter
Access Full Newsletter
MEET DR GRAHAM WOOD, Chief R&D Officer, Altasciences, Canada Top Trends Influencing the CRO Industry

Scientific Journal

A recent case study on the abuse potential of Mirogabalin, a novel α2δ ligand, and our tips on how to conduct a successful Human Abuse Potential (HAP) study.

Bioanalytical Corner

View our latest assay list and register for our upcoming bioanalytical webinars.

Industry News

Get on-demand viewing and access to the Q&A session of our webinar on examining changes in cognition in clinical pharmacology studies.

Published Articles

View our recently published articles in Pharma Tech Outlook and Clinical Trials Insight magazines to see what differentiates Altasciences from other CROs and the techniques we use to enhance safety in clinical trials.

Upcoming Acquisition

Altasciences to acquire a USA-based preclinical contract research organization, adding comprehensive safety testing services to its current full-service clinical and bioanalytical offerings. Check out all our latest news releases!

Upcoming Events

See the full lineup of events we will be attending and don’t miss our scientific presentations at the upcoming AAPS PharmSci 360 meeting on November 4-7 in Washington, DC.

» ACCESS FULL NEWSLETTER
 
Forward the newsletter Contact us  
LinkedIn Twitter Youtube
Algorithme Pharma Clinical Research Vince and Associates Clinical Research Algorithme Pharma USA Clinical Research
© 2018 Altasciences. All Rights Reserved.

Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward.

Send Us A Message

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

You can unsubscribe at any time. For more details, please review our privacy policy.

Stay connected

2021 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy